Compare Humana Inc (HUM) vs ProShares UltraPro Short QQQ ETF (SQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs ProShares UltraPro Short QQQ ETF — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while ProShares UltraPro Short QQQ ETF trades at $38.05. The key difference: Humana Inc pays a 0.92% dividend while ProShares UltraPro Short QQQ ETF pays none, and Humana Inc is trading nearer its 52-week high, ProShares UltraPro Short QQQ ETF nearer its low. Which is the better fit depends on your goals.
| HUM | SQQQ | |
|---|---|---|
Market Cap | $46.31B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $409.42 | $92.95 |
52-Week Low | $163.67 | $36.31 |
Enterprise Value | $53.67B | — |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
SQQQ, the ProShares UltraPro Short QQQ ETF, trades at $37.4, down 3.36% today, reflecting its bearish inverse leverage against the Nasdaq-100. Technical indicators are predominantly bearish, with moving averages signaling strong sell pressure, while oscillators remain neutral. The ETF is designed for short-term tactical hedging against tech declines, not long-term holding, due to daily reset mechanics that can erode value over time.
The outlook for SQQQ is highly speculative, offering potential gains only during sustained Nasdaq-100 downturns. Key risks include volatility decay from leverage, timing challenges, and the structural erosion documented since inception. It serves as a tactical tool for hedging, not a core investment, with success dependent on precise market timing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →
